Is it too soon for mesenchymal stem cell trials in people with ALS?
I Badayan, ME Cudkowicz - Amyotrophic lateral sclerosis, 2008 - Taylor & Francis
I Badayan, ME Cudkowicz
Amyotrophic lateral sclerosis, 2008•Taylor & FrancisAmyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disease affecting
primarily the motor neurons. Stem cell therapy is under development as a possible treatment
approach. A pilot study of intraspinal injections of mesenchymal stem cells (MSC) was
conducted in 9 participants. We review this paper, the rationale, preclinical data and study
design.
primarily the motor neurons. Stem cell therapy is under development as a possible treatment
approach. A pilot study of intraspinal injections of mesenchymal stem cells (MSC) was
conducted in 9 participants. We review this paper, the rationale, preclinical data and study
design.
Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disease affecting primarily the motor neurons. Stem cell therapy is under development as a possible treatment approach. A pilot study of intraspinal injections of mesenchymal stem cells (MSC) was conducted in 9 participants. We review this paper, the rationale, preclinical data and study design.
Taylor & Francis Online